ProShare Advisors LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$342,448
-22.4%
14,239
+3.0%
0.00%0.0%
Q2 2023$441,273
+11.4%
13,820
+6.8%
0.00%0.0%
Q1 2023$396,223
-32.0%
12,940
-13.2%
0.00%
-50.0%
Q4 2022$582,778
-11.8%
14,901
+7.5%
0.00%
-33.3%
Q3 2022$661,000
+28.1%
13,865
+3.7%
0.00%
+50.0%
Q2 2022$516,000
-49.3%
13,371
-24.7%
0.00%0.0%
Q1 2022$1,018,000
-41.7%
17,747
-19.0%
0.00%
-33.3%
Q4 2021$1,746,000
-7.1%
21,903
+1.4%
0.00%
-40.0%
Q3 2021$1,879,000
-37.7%
21,599
-7.8%
0.01%
-44.4%
Q2 2021$3,016,000
+101.5%
23,433
+25.3%
0.01%
+80.0%
Q1 2021$1,497,000
+3.1%
18,707
+5.2%
0.01%0.0%
Q4 2020$1,452,00017,7870.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders